Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Griffin

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2024
Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancerAmanda Webster, Michael Francis, Hannah Gribble, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate CancerAnna C Wilkins, Barry Gusterson, Zsolt Szijgyarto, et al.
BMC Medical Research Methodology|July 27, 2020
Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practiceAgnieszka Lemanska, Rachel C Byford, Clare Cruickshank, et al.
The British Journal of Radiology|March 13, 2025
Radiation-induced lymphocyte apoptosis and chromosomic aberrations for prediction of toxicities in patients undergoing radical radiotherapy for breast or prostate cancersDavid Azria, Joanne S Haviland, Muriel Brengues, et al.
Clinical and Translational Radiation Oncology|September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2025
Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trialsSzeyi Ng, Anna M Kirby, Lucy S Kilburn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 19, 2012
Conducting radiogenomic research--do not forget careful consideration of the clinical dataChristian Nicolaj Andreassen, Gillian C Barnett, Johannes A Langendijk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 6, 2015
The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgeryFrederick R Bartlett, Ruth M Colgan, Ellen M Donovan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 25, 2025
Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trialSzeyi Ng, Lucy S Kilburn, Anna M Kirby, et al.
International Journal of Radiation Oncology, Biology, Physics|January 12, 2022
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP TrialAlison Tree, Clare Griffin, Isabel Syndikus, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2024
Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancerAmanda Webster, Michael Francis, Hannah Gribble, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate CancerAnna C Wilkins, Barry Gusterson, Zsolt Szijgyarto, et al.
BMC Medical Research Methodology|July 27, 2020
Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practiceAgnieszka Lemanska, Rachel C Byford, Clare Cruickshank, et al.
The British Journal of Radiology|March 13, 2025
Radiation-induced lymphocyte apoptosis and chromosomic aberrations for prediction of toxicities in patients undergoing radical radiotherapy for breast or prostate cancersDavid Azria, Joanne S Haviland, Muriel Brengues, et al.
Clinical and Translational Radiation Oncology|September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2025
Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trialsSzeyi Ng, Anna M Kirby, Lucy S Kilburn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 19, 2012
Conducting radiogenomic research--do not forget careful consideration of the clinical dataChristian Nicolaj Andreassen, Gillian C Barnett, Johannes A Langendijk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 6, 2015
The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgeryFrederick R Bartlett, Ruth M Colgan, Ellen M Donovan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 25, 2025
Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trialSzeyi Ng, Lucy S Kilburn, Anna M Kirby, et al.
International Journal of Radiation Oncology, Biology, Physics|January 12, 2022
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP TrialAlison Tree, Clare Griffin, Isabel Syndikus, et al.
Pageof 4